Selected research
Industry Research
Naloxone Industry Research Report 2026
Market perspective
The global Naloxone market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Naloxone is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Naloxone is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Naloxone is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Naloxone include ADAPT Pharma, Amneal Pharmaceuticals, Amphastar Pharmaceuticals, Kaleo, West Ward Pharmaceuticals, Pfizer, Mylan and Sandoz, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Naloxone market in terms of revenue (US$ million) and, where applicable, sales volume (W Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Naloxone Market by Company
ADAPT Pharma
Amneal Pharmaceuticals
Amphastar Pharmaceuticals
Kaleo
West Ward Pharmaceuticals
Pfizer
Mylan
Sandoz
Naloxone Segment by Type
Spray Forms
Injectable Forms
Naloxone Segment by Application
Hospital Pharmacies
Drug Store
Online
Naloxone Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Naloxone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Naloxone and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Naloxone.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Naloxone manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Naloxone by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Naloxone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Spray Forms
- Injectable Forms
Applications
- Hospital Pharmacies
- Drug Store
- Online
Companies covered
- ADAPT Pharma
- Amneal Pharmaceuticals
- Amphastar Pharmaceuticals
- Kaleo
- West Ward Pharmaceuticals
- Pfizer
- Mylan
- Sandoz
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Naloxone Market Size (2021-2032)
- 2.2.2 Global Naloxone Sales (2021-2032)
- 2.2.3 Global Naloxone Market Average Price (2021-2032)
- 2.3 Naloxone by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Spray Forms
- 2.3.3 Injectable Forms
- 2.4 Naloxone by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital Pharmacies
- 2.4.3 Drug Store
- 2.4.4 Online
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Naloxone Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Naloxone Sales (W Units) of Manufacturers (2021-2026)
- 3.3 Global Naloxone Revenue of Manufacturers (2021-2026)
- 3.4 Global Naloxone Average Price by Manufacturers (2021-2026)
- 3.5 Global Naloxone Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Naloxone, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Naloxone, Product Type & Application
- 3.8 Global Manufacturers of Naloxone, Established Date
- 3.9 Global Naloxone Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 ADAPT Pharma
- 4.1.1 ADAPT Pharma Company Information
- 4.1.2 ADAPT Pharma Business Overview
- 4.1.3 ADAPT Pharma Naloxone Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 ADAPT Pharma Naloxone Product Portfolio
- 4.1.5 ADAPT Pharma Recent Developments
- 4.2 Amneal Pharmaceuticals
- 4.2.1 Amneal Pharmaceuticals Company Information
- 4.2.2 Amneal Pharmaceuticals Business Overview
- 4.2.3 Amneal Pharmaceuticals Naloxone Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Amneal Pharmaceuticals Naloxone Product Portfolio
- 4.2.5 Amneal Pharmaceuticals Recent Developments
- 4.3 Amphastar Pharmaceuticals
- 4.3.1 Amphastar Pharmaceuticals Company Information
- 4.3.2 Amphastar Pharmaceuticals Business Overview
- 4.3.3 Amphastar Pharmaceuticals Naloxone Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Amphastar Pharmaceuticals Naloxone Product Portfolio
- 4.3.5 Amphastar Pharmaceuticals Recent Developments
- 4.4 Kaleo
- 4.4.1 Kaleo Company Information
- 4.4.2 Kaleo Business Overview
- 4.4.3 Kaleo Naloxone Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Kaleo Naloxone Product Portfolio
- 4.4.5 Kaleo Recent Developments
- 4.5 West Ward Pharmaceuticals
- 4.5.1 West Ward Pharmaceuticals Company Information
- 4.5.2 West Ward Pharmaceuticals Business Overview
- 4.5.3 West Ward Pharmaceuticals Naloxone Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 West Ward Pharmaceuticals Naloxone Product Portfolio
- 4.5.5 West Ward Pharmaceuticals Recent Developments
- 4.6 Pfizer
- 4.6.1 Pfizer Company Information
- 4.6.2 Pfizer Business Overview
- 4.6.3 Pfizer Naloxone Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Pfizer Naloxone Product Portfolio
- 4.6.5 Pfizer Recent Developments
- 4.7 Mylan
- 4.7.1 Mylan Company Information
- 4.7.2 Mylan Business Overview
- 4.7.3 Mylan Naloxone Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Mylan Naloxone Product Portfolio
- 4.7.5 Mylan Recent Developments
- 4.8 Sandoz
- 4.8.1 Sandoz Company Information
- 4.8.2 Sandoz Business Overview
- 4.8.3 Sandoz Naloxone Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Sandoz Naloxone Product Portfolio
- 4.8.5 Sandoz Recent Developments
5 Global Naloxone Market Scenario by Region
- 5.1 Global Naloxone Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Naloxone Sales by Region: 2021-2032
- 5.2.1 Global Naloxone Sales by Region: 2021-2026
- 5.2.2 Global Naloxone Sales by Region: 2027-2032
- 5.3 Global Naloxone Revenue by Region: 2021-2032
- 5.3.1 Global Naloxone Revenue by Region: 2021-2026
- 5.3.2 Global Naloxone Revenue by Region: 2027-2032
- 5.4 North America Naloxone Market Facts & Figures by Country
- 5.4.1 North America Naloxone Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Naloxone Sales by Country (2021-2032)
- 5.4.3 North America Naloxone Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Naloxone Market Facts & Figures by Country
- 5.5.1 Europe Naloxone Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Naloxone Sales by Country (2021-2032)
- 5.5.3 Europe Naloxone Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Naloxone Market Facts & Figures by Country
- 5.6.1 Asia Pacific Naloxone Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Naloxone Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Naloxone Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Naloxone Market Facts & Figures by Country
- 5.7.1 South America Naloxone Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Naloxone Sales by Country (2021-2032)
- 5.7.3 South America Naloxone Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.7.7 Colombia
- 5.8 Middle East and Africa Naloxone Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Naloxone Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Naloxone Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Naloxone Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Naloxone Sales by Type (2021-2032)
- 6.1.1 Global Naloxone Sales by Type (2021-2032) & (W Units)
- 6.1.2 Global Naloxone Sales Market Share by Type (2021-2032)
- 6.2 Global Naloxone Revenue by Type (2021-2032)
- 6.2.1 Global Naloxone Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Naloxone Revenue Market Share by Type (2021-2032)
- 6.3 Global Naloxone Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Naloxone Sales by Application (2021-2032)
- 7.1.1 Global Naloxone Sales by Application (2021-2032) & (W Units)
- 7.1.2 Global Naloxone Sales Market Share by Application (2021-2032)
- 7.2 Global Naloxone Revenue by Application (2021-2032)
- 7.2.1 Global Naloxone Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Naloxone Revenue Market Share by Application (2021-2032)
- 7.3 Global Naloxone Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Naloxone Value Chain Analysis
- 8.1.1 Naloxone Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Naloxone Production Mode & Process
- 8.2 Naloxone Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Naloxone Distributors
- 8.2.3 Naloxone Customers
9 Global Naloxone Analyzing Market Dynamics
- 9.1 Naloxone Industry Trends
- 9.2 Naloxone Industry Drivers
- 9.3 Naloxone Industry Opportunities and Challenges
- 9.4 Naloxone Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst